Einārs Loža

Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation

Janis Kuka, Edgars Liepinsh, Marina Makrecka‐Kuka et al. · Life Sciences · 2014 · 95 citations

Dysbiosis, L-carnitine Microbial Degradation, Intestinal Microbiota-dependent Production +8

Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer

Chengheng Liao, Yang Zhang, Cheng Fan et al. · Cancer Discovery · 2020 · 66 citations · Full text

Targeting Carnitine Biosynthesis: Discovery of New Inhibitors against γ-Butyrobetaine Hydroxylase

Kaspars Tārs, Ja̅nis Leita̅ns, Andris Kazāks et al. · Journal of Medicinal Chemistry · 2014 · 48 citations · Full text

Enzymatic Modification, Pharmaceutical Chemistry, Molecular Pharmacology +19

Inhibition of L‐carnitine biosynthesis and transport by methyl‐γ‐butyrobetaine decreases fatty acid oxidation and protects against myocardial infarction

Edgars Liepinsh, Marina Makrecka‐Kuka, Janis Kuka et al. · British Journal of Pharmacology · 2014 · 42 citations · Full text

Novel Sulfonamide Derivatives as Inhibitors of Histone Deacetylase

Paul W. Finn, Morwena Bandara, Chris Butcher et al. · Helvetica Chimica Acta · 2005 · 41 citations · Full text

Pharmaceutical Science, Chemical Biology, Pharmaceutical Chemistry +16